Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.42557641 |
2 | positive regulation of histone deacetylation (GO:0031065) | 4.29152159 |
3 | modulation by virus of host process (GO:0019054) | 4.22556289 |
4 | negative regulation of cell size (GO:0045792) | 4.11727699 |
5 | mannose metabolic process (GO:0006013) | 4.08916005 |
6 | sodium ion export (GO:0071436) | 3.98007194 |
7 | thymic T cell selection (GO:0045061) | 3.96367518 |
8 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.90369757 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85953403 |
10 | positive thymic T cell selection (GO:0045059) | 3.84331980 |
11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83286506 |
12 | modulation by symbiont of host cellular process (GO:0044068) | 3.76290039 |
13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.73403563 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70089511 |
15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.69118446 |
16 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.69039989 |
17 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.66878207 |
18 | plasma membrane repair (GO:0001778) | 3.60711826 |
19 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.58383505 |
20 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.58185491 |
21 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.53312310 |
22 | modulation by symbiont of host immune response (GO:0052553) | 3.48935648 |
23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48935648 |
24 | modulation by symbiont of host defense response (GO:0052031) | 3.48935648 |
25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48935648 |
26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48935648 |
27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48935648 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45524736 |
29 | response to muramyl dipeptide (GO:0032495) | 3.45323282 |
30 | peptidyl-lysine dimethylation (GO:0018027) | 3.43907470 |
31 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.41188367 |
32 | synaptic vesicle maturation (GO:0016188) | 3.35361968 |
33 | cell communication by electrical coupling (GO:0010644) | 3.35292538 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.31579684 |
35 | T cell selection (GO:0045058) | 3.27891750 |
36 | pre-miRNA processing (GO:0031054) | 3.27723099 |
37 | apoptotic process involved in morphogenesis (GO:0060561) | 3.25578150 |
38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20132694 |
39 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.17982099 |
40 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16773774 |
41 | macrophage activation involved in immune response (GO:0002281) | 3.16154479 |
42 | regulation of chromatin binding (GO:0035561) | 3.15873207 |
43 | germinal center formation (GO:0002467) | 3.15190504 |
44 | regulation of cholesterol homeostasis (GO:2000188) | 3.15159458 |
45 | negative thymic T cell selection (GO:0045060) | 3.05831618 |
46 | locomotory exploration behavior (GO:0035641) | 3.04633787 |
47 | NIK/NF-kappaB signaling (GO:0038061) | 3.03501848 |
48 | carnitine shuttle (GO:0006853) | 3.02170035 |
49 | activation of protein kinase A activity (GO:0034199) | 3.00944734 |
50 | tolerance induction (GO:0002507) | 3.00525897 |
51 | regulation of ARF protein signal transduction (GO:0032012) | 3.00520593 |
52 | negative regulation of viral release from host cell (GO:1902187) | 3.00234822 |
53 | signal complex assembly (GO:0007172) | 2.99961469 |
54 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.98958089 |
55 | detection of bacterium (GO:0016045) | 2.97290860 |
56 | cellular response to virus (GO:0098586) | 2.97148128 |
57 | positive T cell selection (GO:0043368) | 2.97000706 |
58 | leukocyte aggregation (GO:0070486) | 2.95350762 |
59 | cardiac myofibril assembly (GO:0055003) | 2.94418884 |
60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.91505744 |
61 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.90232888 |
62 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.89836140 |
63 | response to peptidoglycan (GO:0032494) | 2.88918558 |
64 | regulation of ARF GTPase activity (GO:0032312) | 2.88512327 |
65 | B cell receptor signaling pathway (GO:0050853) | 2.87971901 |
66 | detection of other organism (GO:0098543) | 2.86266314 |
67 | cardiac muscle contraction (GO:0060048) | 2.85287083 |
68 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.85197209 |
69 | negative T cell selection (GO:0043383) | 2.84560814 |
70 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.83059009 |
71 | adherens junction assembly (GO:0034333) | 2.82757798 |
72 | histone H3-K36 demethylation (GO:0070544) | 2.82491004 |
73 | cell-substrate adherens junction assembly (GO:0007045) | 2.82054853 |
74 | focal adhesion assembly (GO:0048041) | 2.82054853 |
75 | cellular potassium ion homeostasis (GO:0030007) | 2.81627438 |
76 | potassium ion import (GO:0010107) | 2.81349118 |
77 | positive regulation of protein deacetylation (GO:0090312) | 2.80724457 |
78 | activation of Rac GTPase activity (GO:0032863) | 2.76357490 |
79 | neutrophil activation involved in immune response (GO:0002283) | 2.76180813 |
80 | response to laminar fluid shear stress (GO:0034616) | 2.76030863 |
81 | NLS-bearing protein import into nucleus (GO:0006607) | 2.75224367 |
82 | regulation of histone H3-K27 methylation (GO:0061085) | 2.73391308 |
83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.71210599 |
84 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.70904817 |
85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69888854 |
86 | embryonic process involved in female pregnancy (GO:0060136) | 2.69598294 |
87 | sarcomere organization (GO:0045214) | 2.69287171 |
88 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68811497 |
89 | fatty acid transmembrane transport (GO:1902001) | 2.68600593 |
90 | regulation of necroptotic process (GO:0060544) | 2.68367013 |
91 | regulation of leukocyte degranulation (GO:0043300) | 2.68259909 |
92 | modulation by virus of host morphology or physiology (GO:0019048) | 2.67208824 |
93 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.65133929 |
94 | activation of MAPKKK activity (GO:0000185) | 2.63459304 |
95 | positive regulation of Rap GTPase activity (GO:0032854) | 2.63100779 |
96 | cell communication involved in cardiac conduction (GO:0086065) | 2.62826038 |
97 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.62120067 |
98 | response to interleukin-15 (GO:0070672) | 2.61750886 |
99 | negative regulation of cell killing (GO:0031342) | 2.61377906 |
100 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.61377906 |
101 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.60965151 |
102 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.59775598 |
103 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.58852577 |
104 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.58248742 |
105 | regulation of fatty acid oxidation (GO:0046320) | 2.56700166 |
106 | positive regulation of protein dephosphorylation (GO:0035307) | 2.56489201 |
107 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56460110 |
108 | histone H4 deacetylation (GO:0070933) | 2.55962074 |
109 | positive regulation of glycogen metabolic process (GO:0070875) | 2.55524064 |
110 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.55324828 |
111 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53280075 |
112 | stress fiber assembly (GO:0043149) | 2.52961747 |
113 | negative regulation of necroptotic process (GO:0060546) | 2.52752187 |
114 | negative regulation of myotube differentiation (GO:0010832) | 2.52712971 |
115 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.51186133 |
116 | negative regulation of heart growth (GO:0061117) | 2.51186133 |
117 | 2-oxoglutarate metabolic process (GO:0006103) | 2.50839431 |
118 | regulation of p38MAPK cascade (GO:1900744) | 2.50797062 |
119 | regulation of defense response to virus by virus (GO:0050690) | 2.49433158 |
120 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.48574578 |
121 | megakaryocyte development (GO:0035855) | 2.48107436 |
122 | protein localization to endosome (GO:0036010) | 2.47851038 |
123 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.45812640 |
124 | positive regulation of myotube differentiation (GO:0010831) | 2.45744543 |
125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.45484301 |
126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.43461843 |
127 | B cell homeostasis (GO:0001782) | 2.43414070 |
128 | layer formation in cerebral cortex (GO:0021819) | 2.43055276 |
129 | establishment of nucleus localization (GO:0040023) | 2.42826330 |
130 | cell-substrate junction assembly (GO:0007044) | 2.42015828 |
131 | stress granule assembly (GO:0034063) | 2.41880220 |
132 | negative regulation of potassium ion transport (GO:0043267) | 2.41325187 |
133 | regulation of translational termination (GO:0006449) | 2.41144549 |
134 | negative regulation of innate immune response (GO:0045824) | 2.40252931 |
135 | macroautophagy (GO:0016236) | 2.39717772 |
136 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.39598436 |
137 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.38339235 |
138 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.37308019 |
139 | regulation of mast cell degranulation (GO:0043304) | 2.37021321 |
140 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.36442026 |
141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.36316793 |
142 | cellular sodium ion homeostasis (GO:0006883) | 2.35858796 |
143 | detection of external biotic stimulus (GO:0098581) | 2.35268232 |
144 | Peyers patch development (GO:0048541) | 2.35198633 |
145 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.35198633 |
146 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.34856507 |
147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.34360031 |
148 | regulation of T cell tolerance induction (GO:0002664) | 2.33923277 |
149 | maternal placenta development (GO:0001893) | 2.33576787 |
150 | myofibril assembly (GO:0030239) | 2.33147737 |
151 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.32916518 |
152 | regulation of translational fidelity (GO:0006450) | 2.32862571 |
153 | response to type I interferon (GO:0034340) | 2.32604542 |
154 | lysine metabolic process (GO:0006553) | 2.32381227 |
155 | lysine catabolic process (GO:0006554) | 2.32381227 |
156 | regulation of B cell differentiation (GO:0045577) | 2.32260688 |
157 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.29894494 |
158 | alanine transport (GO:0032328) | 2.29125949 |
159 | regulation of tight junction assembly (GO:2000810) | 2.28186983 |
160 | carnitine transmembrane transport (GO:1902603) | 2.27493943 |
161 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.26892796 |
162 | regulation of histone deacetylation (GO:0031063) | 2.25479711 |
163 | peptidyl-threonine phosphorylation (GO:0018107) | 2.24998543 |
164 | regulation of hippo signaling (GO:0035330) | 2.24420134 |
165 | histone H3-K9 demethylation (GO:0033169) | 2.22125435 |
166 | membrane repolarization (GO:0086009) | 2.19499039 |
167 | regulation of the force of heart contraction (GO:0002026) | 2.18998769 |
168 | peptidyl-threonine modification (GO:0018210) | 2.17005844 |
169 | proline transport (GO:0015824) | 2.16566099 |
170 | tricarboxylic acid metabolic process (GO:0072350) | 2.16450636 |
171 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.16243670 |
172 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.16121901 |
173 | regulation of synapse structural plasticity (GO:0051823) | 2.15259562 |
174 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.15258529 |
175 | potassium ion homeostasis (GO:0055075) | 2.14780517 |
176 | heterochromatin organization (GO:0070828) | 2.14429755 |
177 | growth hormone secretion (GO:0030252) | 2.14079080 |
178 | regulation of early endosome to late endosome transport (GO:2000641) | 2.13322271 |
179 | positive regulation of nuclease activity (GO:0032075) | 2.12032090 |
180 | striated muscle contraction (GO:0006941) | 2.11699513 |
181 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.11536074 |
182 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.11535396 |
183 | amino-acid betaine transport (GO:0015838) | 2.10902227 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.06905715 |
2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.98469140 |
3 | MYC_22102868_ChIP-Seq_BL_Human | 2.94238881 |
4 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.76221286 |
5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.75629183 |
6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44654388 |
7 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.38166886 |
8 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.36799290 |
9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.34977801 |
10 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.29263994 |
11 | KDM2B_26808549_Chip-Seq_K562_Human | 2.18113096 |
12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07976619 |
13 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.04257645 |
14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04018472 |
15 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.02912083 |
16 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.96643041 |
17 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.94496385 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.94147986 |
19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.93595439 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.91801488 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90041690 |
22 | MAF_26560356_Chip-Seq_TH2_Human | 1.89996449 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89852410 |
24 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88579934 |
25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88033397 |
26 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.87827501 |
27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86225081 |
28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80657763 |
29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79861886 |
30 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.71677593 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.69442974 |
32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66676749 |
33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66352927 |
34 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65620201 |
35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.64899605 |
36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64230037 |
37 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.63816147 |
38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63360687 |
39 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.61972374 |
40 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.61859485 |
41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61709371 |
42 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.56943630 |
43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.56367900 |
44 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.55431609 |
45 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.54581330 |
46 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53162289 |
47 | * P68_20966046_ChIP-Seq_HELA_Human | 1.52058665 |
48 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.51274906 |
49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.50568892 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47869376 |
51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47479964 |
52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.47033441 |
53 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45892647 |
54 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45892647 |
55 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45689675 |
56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45131480 |
57 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.42956020 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42877786 |
59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42510567 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36526755 |
61 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34755112 |
62 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.34429221 |
63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.32494099 |
64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.32449712 |
65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31299188 |
66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30740856 |
67 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30153742 |
68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29460117 |
69 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27961586 |
70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27646190 |
71 | MAF_26560356_Chip-Seq_TH1_Human | 1.27264514 |
72 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26916602 |
73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26552581 |
74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26341918 |
75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24970048 |
76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24267847 |
77 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23437739 |
78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21400481 |
79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20669293 |
80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20652592 |
81 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.19670011 |
82 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19470413 |
83 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19402015 |
84 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19064969 |
85 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.18868158 |
86 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.18046519 |
87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17628899 |
88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17580903 |
89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17440799 |
90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16995270 |
91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16904413 |
92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16840895 |
93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13855346 |
94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13804711 |
95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13363079 |
96 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.12805762 |
97 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12771712 |
98 | MYB_26560356_Chip-Seq_TH1_Human | 1.12669477 |
99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12568570 |
100 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11417493 |
101 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.11194567 |
102 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11192903 |
103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10119115 |
104 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09976210 |
105 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09408360 |
106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08879828 |
107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08575947 |
108 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.08469107 |
109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08402762 |
110 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08099206 |
111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.07232510 |
112 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06020007 |
113 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05960285 |
114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05774386 |
115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05001811 |
116 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04721494 |
117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03646065 |
118 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.03442449 |
119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02567843 |
120 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02116762 |
121 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02070346 |
122 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02036175 |
123 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.01813750 |
124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01679126 |
125 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01258107 |
126 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01149603 |
127 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00294225 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98581624 |
129 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98268558 |
130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96691727 |
131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96059896 |
132 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95694608 |
133 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94465624 |
134 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94271242 |
135 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94007510 |
136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93882277 |
137 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92928443 |
138 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92380850 |
139 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92011154 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 3.82344129 |
2 | MP0003705_abnormal_hypodermis_morpholog | 3.51838130 |
3 | MP0003436_decreased_susceptibility_to | 3.42629512 |
4 | MP0008961_abnormal_basal_metabolism | 3.41636208 |
5 | MP0000751_myopathy | 2.99163693 |
6 | MP0004859_abnormal_synaptic_plasticity | 2.96843393 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 2.94988019 |
8 | MP0002909_abnormal_adrenal_gland | 2.65486268 |
9 | MP0004084_abnormal_cardiac_muscle | 2.58319195 |
10 | MP0004130_abnormal_muscle_cell | 2.54681293 |
11 | MP0003763_abnormal_thymus_physiology | 2.52618653 |
12 | MP0003646_muscle_fatigue | 2.50472124 |
13 | MP0004233_abnormal_muscle_weight | 2.42932628 |
14 | MP0000685_abnormal_immune_system | 2.32828424 |
15 | MP0005670_abnormal_white_adipose | 2.28036687 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.27516305 |
17 | MP0004087_abnormal_muscle_fiber | 2.23499738 |
18 | MP0004036_abnormal_muscle_relaxation | 2.18055901 |
19 | MP0002269_muscular_atrophy | 2.13247481 |
20 | MP0008260_abnormal_autophagy | 2.11397522 |
21 | MP0004947_skin_inflammation | 2.07375477 |
22 | MP0001873_stomach_inflammation | 2.07341242 |
23 | MP0005076_abnormal_cell_differentiation | 2.03295862 |
24 | MP0010352_gastrointestinal_tract_polyps | 2.00231784 |
25 | MP0001348_abnormal_lacrimal_gland | 1.99965392 |
26 | MP0003300_gastrointestinal_ulcer | 1.96300186 |
27 | MP0002822_catalepsy | 1.94810307 |
28 | MP0001800_abnormal_humoral_immune | 1.93288353 |
29 | MP0005058_abnormal_lysosome_morphology | 1.91662015 |
30 | MP0000747_muscle_weakness | 1.89919034 |
31 | MP0004381_abnormal_hair_follicle | 1.86598499 |
32 | MP0005000_abnormal_immune_tolerance | 1.85935586 |
33 | MP0002653_abnormal_ependyma_morphology | 1.85732542 |
34 | MP0010630_abnormal_cardiac_muscle | 1.83814903 |
35 | MP0000678_abnormal_parathyroid_gland | 1.80651099 |
36 | MP0005330_cardiomyopathy | 1.79861785 |
37 | MP0005025_abnormal_response_to | 1.79587149 |
38 | MP0004858_abnormal_nervous_system | 1.79585108 |
39 | MP0001835_abnormal_antigen_presentation | 1.79156290 |
40 | MP0003283_abnormal_digestive_organ | 1.76545424 |
41 | MP0005666_abnormal_adipose_tissue | 1.74301645 |
42 | MP0000749_muscle_degeneration | 1.73128488 |
43 | MP0002419_abnormal_innate_immunity | 1.72819260 |
44 | MP0002420_abnormal_adaptive_immunity | 1.71938277 |
45 | MP0001790_abnormal_immune_system | 1.71772003 |
46 | MP0005387_immune_system_phenotype | 1.71772003 |
47 | MP0002723_abnormal_immune_serum | 1.70800047 |
48 | MP0002398_abnormal_bone_marrow | 1.70362841 |
49 | MP0001819_abnormal_immune_cell | 1.69599195 |
50 | MP0000703_abnormal_thymus_morphology | 1.68143739 |
51 | MP0004145_abnormal_muscle_electrophysio | 1.67232695 |
52 | MP0005375_adipose_tissue_phenotype | 1.66788440 |
53 | MP0000003_abnormal_adipose_tissue | 1.66581606 |
54 | MP0003191_abnormal_cellular_cholesterol | 1.64924001 |
55 | MP0002396_abnormal_hematopoietic_system | 1.64596159 |
56 | MP0003303_peritoneal_inflammation | 1.63598443 |
57 | MP0005671_abnormal_response_to | 1.62293970 |
58 | MP0000759_abnormal_skeletal_muscle | 1.62174904 |
59 | MP0004185_abnormal_adipocyte_glucose | 1.55973301 |
60 | MP0002452_abnormal_antigen_presenting | 1.55854126 |
61 | MP0003045_fibrosis | 1.53581172 |
62 | MP0000013_abnormal_adipose_tissue | 1.48492018 |
63 | MP0003453_abnormal_keratinocyte_physiol | 1.46883835 |
64 | MP0000716_abnormal_immune_system | 1.44591977 |
65 | MP0002106_abnormal_muscle_physiology | 1.44529520 |
66 | MP0000858_altered_metastatic_potential | 1.44491843 |
67 | MP0004215_abnormal_myocardial_fiber | 1.43772478 |
68 | MP0002249_abnormal_larynx_morphology | 1.43546438 |
69 | MP0009278_abnormal_bone_marrow | 1.39936009 |
70 | MP0002722_abnormal_immune_system | 1.34681679 |
71 | MP0000750_abnormal_muscle_regeneration | 1.31139020 |
72 | MP0002405_respiratory_system_inflammati | 1.31064014 |
73 | MP0003635_abnormal_synaptic_transmissio | 1.28900527 |
74 | MP0008775_abnormal_heart_ventricle | 1.28634206 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 1.27910603 |
76 | MP0001849_ear_inflammation | 1.27773281 |
77 | MP0001533_abnormal_skeleton_physiology | 1.27582015 |
78 | MP0005409_darkened_coat_color | 1.26430563 |
79 | MP0002429_abnormal_blood_cell | 1.26100675 |
80 | MP0005620_abnormal_muscle_contractility | 1.24468672 |
81 | MP0000733_abnormal_muscle_development | 1.24308239 |
82 | MP0004808_abnormal_hematopoietic_stem | 1.21928568 |
83 | MP0010155_abnormal_intestine_physiology | 1.19955185 |
84 | MP0003724_increased_susceptibility_to | 1.18865864 |
85 | MP0002933_joint_inflammation | 1.18814458 |
86 | MP0008569_lethality_at_weaning | 1.18566588 |
87 | MP0005623_abnormal_meninges_morphology | 1.18439312 |
88 | MP0000689_abnormal_spleen_morphology | 1.17386704 |
89 | MP0005369_muscle_phenotype | 1.14627345 |
90 | MP0002148_abnormal_hypersensitivity_rea | 1.14197082 |
91 | MP0005397_hematopoietic_system_phenotyp | 1.13323110 |
92 | MP0001545_abnormal_hematopoietic_system | 1.13323110 |
93 | MP0005310_abnormal_salivary_gland | 1.12522234 |
94 | MP0003137_abnormal_impulse_conducting | 1.11499185 |
95 | MP0005464_abnormal_platelet_physiology | 1.10314592 |
96 | MP0002998_abnormal_bone_remodeling | 1.09947001 |
97 | MP0003329_amyloid_beta_deposits | 1.09602927 |
98 | MP0002254_reproductive_system_inflammat | 1.09180610 |
99 | MP0002796_impaired_skin_barrier | 1.08506160 |
100 | MP0002234_abnormal_pharynx_morphology | 1.07716119 |
101 | MP0004085_abnormal_heartbeat | 1.05670202 |
102 | MP0000266_abnormal_heart_morphology | 1.04908746 |
103 | MP0002972_abnormal_cardiac_muscle | 1.04743356 |
104 | MP0005365_abnormal_bile_salt | 1.04689246 |
105 | MP0000569_abnormal_digit_pigmentation | 1.03784930 |
106 | MP0005385_cardiovascular_system_phenoty | 1.03156090 |
107 | MP0001544_abnormal_cardiovascular_syste | 1.03156090 |
108 | MP0010329_abnormal_lipoprotein_level | 1.02280162 |
109 | MP0009672_abnormal_birth_weight | 1.02164436 |
110 | MP0003566_abnormal_cell_adhesion | 1.01970654 |
111 | MP0003866_abnormal_defecation | 1.01815373 |
112 | MP0009785_altered_susceptibility_to | 1.01759778 |
113 | MP0008770_decreased_survivor_rate | 0.99451657 |
114 | MP0003172_abnormal_lysosome_physiology | 0.99411055 |
115 | MP0003252_abnormal_bile_duct | 0.99254697 |
116 | MP0002138_abnormal_hepatobiliary_system | 0.98358163 |
117 | MP0003828_pulmonary_edema | 0.96911510 |
118 | MP0003656_abnormal_erythrocyte_physiolo | 0.96662950 |
119 | MP0009931_abnormal_skin_appearance | 0.95943493 |
120 | MP0004510_myositis | 0.95711662 |
121 | MP0001851_eye_inflammation | 0.94708341 |
122 | MP0010234_abnormal_vibrissa_follicle | 0.92671967 |
123 | MP0005187_abnormal_penis_morphology | 0.92271429 |
124 | MP0002877_abnormal_melanocyte_morpholog | 0.91955035 |
125 | MP0005083_abnormal_biliary_tract | 0.91808073 |
126 | MP0001845_abnormal_inflammatory_respons | 0.91315518 |
127 | MP0003091_abnormal_cell_migration | 0.91018338 |
128 | MP0004811_abnormal_neuron_physiology | 0.90714074 |
129 | MP0004197_abnormal_fetal_growth/weight/ | 0.88833139 |
130 | MP0002971_abnormal_brown_adipose | 0.87423374 |
131 | MP0005501_abnormal_skin_physiology | 0.87329750 |
132 | MP0003787_abnormal_imprinting | 0.87117545 |
133 | MP0002078_abnormal_glucose_homeostasis | 0.87088510 |
134 | MP0005167_abnormal_blood-brain_barrier | 0.87042890 |
135 | MP0002970_abnormal_white_adipose | 0.84668617 |
136 | MP0004264_abnormal_extraembryonic_tissu | 0.82942864 |
137 | MP0009840_abnormal_foam_cell | 0.82824736 |
138 | MP0002925_abnormal_cardiovascular_devel | 0.82279323 |
139 | MP0002127_abnormal_cardiovascular_syste | 0.82069789 |
140 | MP0008874_decreased_physiological_sensi | 0.81718830 |
141 | MP0002089_abnormal_postnatal_growth/wei | 0.81207365 |
142 | MP0002063_abnormal_learning/memory/cond | 0.80345691 |
143 | MP0003183_abnormal_peptide_metabolism | 0.79443689 |
144 | MP0003115_abnormal_respiratory_system | 0.77872280 |
145 | MP0003122_maternal_imprinting | 0.76885443 |
146 | MP0003075_altered_response_to | 0.76205027 |
147 | MP0000609_abnormal_liver_physiology | 0.76203557 |
148 | MP0009703_decreased_birth_body | 0.75488209 |
149 | MP0002088_abnormal_embryonic_growth/wei | 0.74540901 |
150 | MP0005390_skeleton_phenotype | 0.74326648 |
151 | MP0003633_abnormal_nervous_system | 0.74247438 |
152 | MP0003279_aneurysm | 0.73149284 |
153 | MP0003984_embryonic_growth_retardation | 0.72579160 |
154 | MP0000490_abnormal_crypts_of | 0.71645427 |
155 | MP0002108_abnormal_muscle_morphology | 0.71557753 |
156 | MP0002086_abnormal_extraembryonic_tissu | 0.71380016 |
157 | MP0006138_congestive_heart_failure | 0.71343038 |
158 | MP0009115_abnormal_fat_cell | 0.70735760 |
159 | MP0002084_abnormal_developmental_patter | 0.70477953 |
160 | MP0002064_seizures | 0.69088470 |
161 | MP0005334_abnormal_fat_pad | 0.69062379 |
162 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68648545 |
163 | MP0008469_abnormal_protein_level | 0.68602858 |
164 | MP0002118_abnormal_lipid_homeostasis | 0.66954318 |
165 | MP0009046_muscle_twitch | 0.64531258 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Obstructive sleep apnea (HP:0002870) | 4.22333143 |
2 | Eczematoid dermatitis (HP:0000976) | 3.75387038 |
3 | Exercise-induced myalgia (HP:0003738) | 3.58830987 |
4 | Abnormality of the lower motor neuron (HP:0002366) | 3.49987974 |
5 | Cerebral aneurysm (HP:0004944) | 3.35686072 |
6 | Difficulty running (HP:0009046) | 3.28671801 |
7 | Exercise-induced muscle cramps (HP:0003710) | 3.26831224 |
8 | Hyporeflexia of lower limbs (HP:0002600) | 3.25863251 |
9 | Hyperacusis (HP:0010780) | 3.22134482 |
10 | Dysmetric saccades (HP:0000641) | 3.19645327 |
11 | Increased IgE level (HP:0003212) | 3.18103430 |
12 | Macroorchidism (HP:0000053) | 3.04021927 |
13 | Sudden death (HP:0001699) | 2.99640854 |
14 | Bundle branch block (HP:0011710) | 2.98235271 |
15 | Myopathic facies (HP:0002058) | 2.92567344 |
16 | Neoplasm of the heart (HP:0100544) | 2.92403131 |
17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.91835116 |
18 | Increased connective tissue (HP:0009025) | 2.83505649 |
19 | Asymmetric septal hypertrophy (HP:0001670) | 2.81182523 |
20 | Myoglobinuria (HP:0002913) | 2.80752417 |
21 | Distal upper limb amyotrophy (HP:0007149) | 2.77058680 |
22 | Upper limb amyotrophy (HP:0009129) | 2.77058680 |
23 | Distal lower limb amyotrophy (HP:0008944) | 2.76677489 |
24 | Broad face (HP:0000283) | 2.73466558 |
25 | Gastrointestinal infarctions (HP:0005244) | 2.72401326 |
26 | Recurrent bacterial skin infections (HP:0005406) | 2.70602416 |
27 | Pustule (HP:0200039) | 2.69400256 |
28 | Recurrent abscess formation (HP:0002722) | 2.57394876 |
29 | Cellulitis (HP:0100658) | 2.57252677 |
30 | Myositis (HP:0100614) | 2.55115194 |
31 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.52755150 |
32 | Distal lower limb muscle weakness (HP:0009053) | 2.50459869 |
33 | Hand muscle atrophy (HP:0009130) | 2.48400552 |
34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.47788008 |
35 | Obstructive lung disease (HP:0006536) | 2.47788008 |
36 | EMG: neuropathic changes (HP:0003445) | 2.46137254 |
37 | Difficulty climbing stairs (HP:0003551) | 2.45290928 |
38 | Ventricular fibrillation (HP:0001663) | 2.43111117 |
39 | Astrocytoma (HP:0009592) | 2.43044988 |
40 | Abnormality of the astrocytes (HP:0100707) | 2.43044988 |
41 | Hypochromic anemia (HP:0001931) | 2.43003488 |
42 | Insomnia (HP:0100785) | 2.41242797 |
43 | Aneurysm (HP:0002617) | 2.39494377 |
44 | Abnormality of macrophages (HP:0004311) | 2.36448653 |
45 | Gastrointestinal inflammation (HP:0004386) | 2.35109871 |
46 | Disproportionate tall stature (HP:0001519) | 2.33752534 |
47 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.33167076 |
48 | Ventricular tachycardia (HP:0004756) | 2.32537863 |
49 | Meningitis (HP:0001287) | 2.31780329 |
50 | Achilles tendon contracture (HP:0001771) | 2.31706101 |
51 | Colitis (HP:0002583) | 2.29646024 |
52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.29362316 |
53 | Subaortic stenosis (HP:0001682) | 2.29362316 |
54 | Enlarged penis (HP:0000040) | 2.28996455 |
55 | Recurrent fungal infections (HP:0002841) | 2.28298290 |
56 | Easy fatigability (HP:0003388) | 2.27136045 |
57 | Abnormality of the Achilles tendon (HP:0005109) | 2.26721424 |
58 | Stridor (HP:0010307) | 2.25656733 |
59 | Elfin facies (HP:0004428) | 2.24147877 |
60 | Lymphangioma (HP:0100764) | 2.22887044 |
61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21596992 |
62 | Mediastinal lymphadenopathy (HP:0100721) | 2.21462146 |
63 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21203324 |
64 | Broad metatarsal (HP:0001783) | 2.20511222 |
65 | Gastrointestinal stroma tumor (HP:0100723) | 2.19515028 |
66 | Rectal prolapse (HP:0002035) | 2.17907139 |
67 | Hypertensive crisis (HP:0100735) | 2.17254190 |
68 | Hemorrhage of the eye (HP:0011885) | 2.16957402 |
69 | Resting tremor (HP:0002322) | 2.16119096 |
70 | Fibroma (HP:0010614) | 2.15452966 |
71 | Orchitis (HP:0100796) | 2.14725158 |
72 | Emphysema (HP:0002097) | 2.13687177 |
73 | Renovascular hypertension (HP:0100817) | 2.13302002 |
74 | Calf muscle hypertrophy (HP:0008981) | 2.12648800 |
75 | Long palpebral fissure (HP:0000637) | 2.11307175 |
76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.11290174 |
77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10214833 |
78 | Ulnar deviation of the wrist (HP:0003049) | 2.10111939 |
79 | Type 1 muscle fiber predominance (HP:0003803) | 2.08128817 |
80 | Abnormality of the thoracic spine (HP:0100711) | 2.07544511 |
81 | Muscle fiber splitting (HP:0003555) | 2.07334915 |
82 | Turricephaly (HP:0000262) | 2.07212124 |
83 | Atrioventricular block (HP:0001678) | 2.07032023 |
84 | Hypercortisolism (HP:0001578) | 2.06588169 |
85 | Hemiplegia (HP:0002301) | 2.06235921 |
86 | Hamartoma of the eye (HP:0010568) | 2.06112008 |
87 | Inflammation of the large intestine (HP:0002037) | 2.05651509 |
88 | Heart block (HP:0012722) | 2.04306165 |
89 | Frequent falls (HP:0002359) | 2.04093557 |
90 | Annular pancreas (HP:0001734) | 2.03549856 |
91 | Ependymoma (HP:0002888) | 2.03514167 |
92 | Fibrous tissue neoplasm (HP:0012316) | 2.02937006 |
93 | Abnormality of the columella (HP:0009929) | 2.00198323 |
94 | Visual hallucinations (HP:0002367) | 2.00009109 |
95 | Pointed chin (HP:0000307) | 1.99378848 |
96 | Chest pain (HP:0100749) | 1.97116883 |
97 | Ventricular arrhythmia (HP:0004308) | 1.96163006 |
98 | Gingivitis (HP:0000230) | 1.95953885 |
99 | Spontaneous hematomas (HP:0007420) | 1.95868234 |
100 | Shallow orbits (HP:0000586) | 1.95713356 |
101 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95249931 |
102 | Impaired social interactions (HP:0000735) | 1.95130707 |
103 | Abnormal social behavior (HP:0012433) | 1.95130707 |
104 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95122342 |
105 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95122342 |
106 | Round ear (HP:0100830) | 1.95026113 |
107 | Metaphyseal cupping (HP:0003021) | 1.94223943 |
108 | Long toe (HP:0010511) | 1.93632262 |
109 | Recurrent skin infections (HP:0001581) | 1.93271796 |
110 | Heterotopia (HP:0002282) | 1.93193573 |
111 | Polygenic inheritance (HP:0010982) | 1.92880084 |
112 | Abnormal atrioventricular conduction (HP:0005150) | 1.92027843 |
113 | Back pain (HP:0003418) | 1.91050887 |
114 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90832279 |
115 | Myotonia (HP:0002486) | 1.90369407 |
116 | Recurrent viral infections (HP:0004429) | 1.90203119 |
117 | Thoracic kyphosis (HP:0002942) | 1.89358416 |
118 | Increased cerebral lipofuscin (HP:0011813) | 1.89050473 |
119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88466714 |
120 | Atrial fibrillation (HP:0005110) | 1.88037983 |
121 | Rapidly progressive (HP:0003678) | 1.88007471 |
122 | Postural instability (HP:0002172) | 1.87473854 |
123 | Slow saccadic eye movements (HP:0000514) | 1.86788427 |
124 | Thin bony cortex (HP:0002753) | 1.85851992 |
125 | Deep palmar crease (HP:0006191) | 1.85546847 |
126 | Striae distensae (HP:0001065) | 1.84648047 |
127 | Renal duplication (HP:0000075) | 1.83900310 |
128 | Abnormality of the calf musculature (HP:0001430) | 1.83814441 |
129 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82843432 |
130 | Primary atrial arrhythmia (HP:0001692) | 1.81979794 |
131 | EMG: myopathic abnormalities (HP:0003458) | 1.81775799 |
132 | Bowel incontinence (HP:0002607) | 1.81735875 |
133 | Vasculitis (HP:0002633) | 1.81330871 |
134 | Right ventricular cardiomyopathy (HP:0011663) | 1.81107282 |
135 | Bulbar palsy (HP:0001283) | 1.80781019 |
136 | Germ cell neoplasia (HP:0100728) | 1.80767556 |
137 | Onion bulb formation (HP:0003383) | 1.80613899 |
138 | Increased serum ferritin (HP:0003281) | 1.80558195 |
139 | Muscle fiber inclusion bodies (HP:0100299) | 1.77430150 |
140 | Central scotoma (HP:0000603) | 1.76270069 |
141 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.76072298 |
142 | Deep venous thrombosis (HP:0002625) | 1.76009278 |
143 | Mitral valve prolapse (HP:0001634) | 1.75435589 |
144 | Pseudobulbar signs (HP:0002200) | 1.74466294 |
145 | Dysostosis multiplex (HP:0000943) | 1.74067506 |
146 | Polycythemia (HP:0001901) | 1.73871500 |
147 | Dislocated radial head (HP:0003083) | 1.72151529 |
148 | Depression (HP:0000716) | 1.71935376 |
149 | Global brain atrophy (HP:0002283) | 1.71895873 |
150 | Urticaria (HP:0001025) | 1.71388200 |
151 | Seborrheic dermatitis (HP:0001051) | 1.71369820 |
152 | Axonal loss (HP:0003447) | 1.70904852 |
153 | Supranuclear gaze palsy (HP:0000605) | 1.70683140 |
154 | Overriding aorta (HP:0002623) | 1.70587210 |
155 | Abnormality of the aortic arch (HP:0012303) | 1.70326446 |
156 | Agammaglobulinemia (HP:0004432) | 1.70018125 |
157 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.70006240 |
158 | Hypertriglyceridemia (HP:0002155) | 1.69074590 |
159 | Supraventricular arrhythmia (HP:0005115) | 1.68864135 |
160 | Encephalitis (HP:0002383) | 1.68572087 |
161 | Ulnar bowing (HP:0003031) | 1.68531100 |
162 | Supraventricular tachycardia (HP:0004755) | 1.68506702 |
163 | Prolonged QT interval (HP:0001657) | 1.68424520 |
164 | Focal seizures (HP:0007359) | 1.68067430 |
165 | Bowel diverticulosis (HP:0005222) | 1.66488951 |
166 | Stomatitis (HP:0010280) | 1.66193091 |
167 | Prolonged bleeding time (HP:0003010) | 1.65898754 |
168 | J-shaped sella turcica (HP:0002680) | 1.65799849 |
169 | Lower limb amyotrophy (HP:0007210) | 1.64855838 |
170 | Obsessive-compulsive behavior (HP:0000722) | 1.64694239 |
171 | Ketoacidosis (HP:0001993) | 1.64194265 |
172 | Reticulocytosis (HP:0001923) | 1.63973614 |
173 | Aortic aneurysm (HP:0004942) | 1.63861179 |
174 | Abnormality of the fingertips (HP:0001211) | 1.63548314 |
175 | Urethral obstruction (HP:0000796) | 1.61338998 |
176 | Genetic anticipation (HP:0003743) | 1.61235650 |
177 | Protrusio acetabuli (HP:0003179) | 1.60686282 |
178 | Status epilepticus (HP:0002133) | 1.60087747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 4.22100541 |
2 | PRPF4B | 3.70523167 |
3 | ICK | 3.39127966 |
4 | SMG1 | 3.26610199 |
5 | PKN2 | 3.04386289 |
6 | PRKD3 | 2.74048099 |
7 | MAP3K10 | 2.60060503 |
8 | EEF2K | 2.58036487 |
9 | TTN | 2.55419485 |
10 | CDK12 | 2.54794755 |
11 | RIPK4 | 2.36603161 |
12 | ERN1 | 2.29939817 |
13 | RIPK1 | 2.27452706 |
14 | PDGFRA | 1.81376837 |
15 | SIK1 | 1.81128749 |
16 | IRAK3 | 1.76949502 |
17 | CAMK1G | 1.74877036 |
18 | TYRO3 | 1.71466913 |
19 | MAP3K9 | 1.65702344 |
20 | SIK2 | 1.64071155 |
21 | TAOK1 | 1.61158008 |
22 | MAP3K7 | 1.60841000 |
23 | KSR2 | 1.52115353 |
24 | IRAK4 | 1.51933185 |
25 | STK38 | 1.48651037 |
26 | SIK3 | 1.46422371 |
27 | DMPK | 1.42773410 |
28 | ALK | 1.39102317 |
29 | PHKG2 | 1.38689679 |
30 | PHKG1 | 1.38689679 |
31 | PTK6 | 1.33656226 |
32 | MAP3K3 | 1.27807001 |
33 | CAMK1D | 1.27475473 |
34 | MTOR | 1.26573248 |
35 | PAK6 | 1.26486791 |
36 | TAOK2 | 1.20926599 |
37 | LMTK2 | 1.18991395 |
38 | PRKCH | 1.18877778 |
39 | FGFR4 | 1.13283261 |
40 | TBK1 | 1.11916928 |
41 | BMX | 1.11522152 |
42 | RET | 1.10218292 |
43 | TYK2 | 1.09135005 |
44 | MAP2K4 | 1.06885422 |
45 | CAMKK1 | 1.06649356 |
46 | NEK1 | 1.05613801 |
47 | GRK6 | 1.04259549 |
48 | MAP3K4 | 1.04165667 |
49 | PDK4 | 1.03017572 |
50 | PDK3 | 1.03017572 |
51 | NTRK3 | 1.00470806 |
52 | DAPK2 | 0.99584889 |
53 | BLK | 0.99577274 |
54 | MAP3K14 | 0.98759377 |
55 | PRKD2 | 0.95044155 |
56 | RPS6KL1 | 0.94536232 |
57 | RPS6KC1 | 0.94536232 |
58 | WNK1 | 0.93308276 |
59 | TAOK3 | 0.89972170 |
60 | BTK | 0.89203666 |
61 | MAP4K1 | 0.87905950 |
62 | DYRK1B | 0.87606140 |
63 | CSK | 0.87235234 |
64 | FGFR2 | 0.87179100 |
65 | SGK3 | 0.86872736 |
66 | MARK2 | 0.85109463 |
67 | CDC42BPA | 0.84822537 |
68 | MAP2K2 | 0.84392676 |
69 | IRAK2 | 0.84147226 |
70 | FES | 0.81796596 |
71 | DDR2 | 0.79432347 |
72 | RPS6KA6 | 0.78602470 |
73 | JAK3 | 0.78237328 |
74 | CAMK4 | 0.77932168 |
75 | MAP3K6 | 0.76973836 |
76 | MAPK7 | 0.76410761 |
77 | NTRK2 | 0.74230839 |
78 | MAP2K6 | 0.74059762 |
79 | UHMK1 | 0.72582752 |
80 | PDGFRB | 0.72275217 |
81 | NTRK1 | 0.72206146 |
82 | LRRK2 | 0.71087577 |
83 | PRKD1 | 0.70823987 |
84 | PINK1 | 0.70705776 |
85 | FGFR3 | 0.70383615 |
86 | * MAP3K1 | 0.70112447 |
87 | LATS1 | 0.67894189 |
88 | HIPK2 | 0.66648870 |
89 | MAP2K3 | 0.66297322 |
90 | IRAK1 | 0.63889429 |
91 | PAK3 | 0.63313212 |
92 | PDK1 | 0.63204141 |
93 | ARAF | 0.62941953 |
94 | PTK2 | 0.62412369 |
95 | LATS2 | 0.61887820 |
96 | PRKAA1 | 0.61688888 |
97 | SYK | 0.61342041 |
98 | SCYL2 | 0.60615305 |
99 | NME2 | 0.59689702 |
100 | IKBKE | 0.58194159 |
101 | FGFR1 | 0.56955183 |
102 | MARK3 | 0.55491389 |
103 | JAK2 | 0.55275696 |
104 | CAMK1 | 0.55224937 |
105 | MINK1 | 0.54940101 |
106 | IKBKB | 0.54896704 |
107 | KSR1 | 0.54347804 |
108 | STK11 | 0.52706426 |
109 | MAP3K13 | 0.51894198 |
110 | TXK | 0.50104112 |
111 | JAK1 | 0.49747364 |
112 | MAP3K8 | 0.49315824 |
113 | MAP3K11 | 0.48695878 |
114 | PDPK1 | 0.48576272 |
115 | PAK2 | 0.47724402 |
116 | ZAP70 | 0.47002966 |
117 | EPHA2 | 0.46992923 |
118 | MAPKAPK3 | 0.45892636 |
119 | MAPK12 | 0.45540643 |
120 | CDK6 | 0.45454453 |
121 | TNK2 | 0.44987510 |
122 | BRAF | 0.44786113 |
123 | CHUK | 0.43780722 |
124 | DAPK1 | 0.43541407 |
125 | EPHB1 | 0.43409508 |
126 | BRD4 | 0.42495252 |
127 | RPS6KA2 | 0.42212258 |
128 | RPS6KA3 | 0.41540334 |
129 | MAPK11 | 0.41351543 |
130 | RPS6KA1 | 0.40880291 |
131 | PTK2B | 0.39901843 |
132 | LCK | 0.39801538 |
133 | MAPK10 | 0.39246593 |
134 | MAPK4 | 0.37165014 |
135 | MAPKAPK2 | 0.37146724 |
136 | ITK | 0.36904553 |
137 | EPHA4 | 0.36897754 |
138 | NEK2 | 0.35869548 |
139 | HCK | 0.35796001 |
140 | MAPK8 | 0.34029430 |
141 | CDK4 | 0.33127522 |
142 | RPS6KB2 | 0.30700519 |
143 | LYN | 0.30455628 |
144 | MELK | 0.30093714 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.73815332 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45314611 |
3 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89255074 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83120819 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77855361 |
6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75717651 |
7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.72091796 |
8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.64920454 |
9 | Lysine degradation_Homo sapiens_hsa00310 | 1.63934494 |
10 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.58918722 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.54190921 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53709744 |
13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.53426020 |
14 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.52673113 |
15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52655612 |
16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46887226 |
17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46634425 |
18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.43218868 |
19 | Insulin resistance_Homo sapiens_hsa04931 | 1.41012468 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38907358 |
21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.38790805 |
22 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.35187114 |
23 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34448710 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33562459 |
25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30796433 |
26 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.30538748 |
27 | Glioma_Homo sapiens_hsa05214 | 1.27651364 |
28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27029444 |
29 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.25228741 |
30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.25185290 |
31 | Insulin secretion_Homo sapiens_hsa04911 | 1.19803307 |
32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.18270865 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.17422430 |
34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16986642 |
35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16902627 |
36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16553541 |
37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14862554 |
38 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.14561113 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.14440966 |
40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14375188 |
41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14223986 |
42 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13965716 |
43 | Bile secretion_Homo sapiens_hsa04976 | 1.12581784 |
44 | Tuberculosis_Homo sapiens_hsa05152 | 1.12473450 |
45 | Measles_Homo sapiens_hsa05162 | 1.11413717 |
46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.10907230 |
47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10834723 |
48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10662499 |
49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10261503 |
50 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.08737283 |
51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.08344419 |
52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06237199 |
53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06234587 |
54 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05049396 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04185226 |
56 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03398526 |
57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02896447 |
58 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.02470762 |
59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02339957 |
60 | * Influenza A_Homo sapiens_hsa05164 | 1.01940781 |
61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.01869739 |
62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01679882 |
63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01543100 |
64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00166347 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.99733386 |
66 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98707716 |
67 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98618433 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98365081 |
69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98189873 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98135556 |
71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97877379 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.96487529 |
73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94754402 |
74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93162217 |
75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92996212 |
76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92787057 |
77 | Salivary secretion_Homo sapiens_hsa04970 | 0.91691893 |
78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.91669444 |
79 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89762249 |
80 | Renin secretion_Homo sapiens_hsa04924 | 0.87588729 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87368467 |
82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86044259 |
83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.85154055 |
84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84580437 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84478544 |
86 | Prostate cancer_Homo sapiens_hsa05215 | 0.83958898 |
87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83222027 |
88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83174852 |
89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82329884 |
90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82179106 |
91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82010190 |
92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81899800 |
93 | Malaria_Homo sapiens_hsa05144 | 0.81037921 |
94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80591093 |
95 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79713160 |
96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.79478976 |
97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79108868 |
98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.78976294 |
99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78239159 |
100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77566005 |
101 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77141924 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77091907 |
103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76631342 |
104 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76104902 |
105 | Focal adhesion_Homo sapiens_hsa04510 | 0.75909953 |
106 | Gap junction_Homo sapiens_hsa04540 | 0.75885228 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75428537 |
108 | Prion diseases_Homo sapiens_hsa05020 | 0.72980675 |
109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72650388 |
110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72362210 |
111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72342598 |
112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72129072 |
113 | Allograft rejection_Homo sapiens_hsa05330 | 0.71095415 |
114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71023717 |
115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70468733 |
116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70302963 |
117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69957811 |
118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68755665 |
119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66242540 |
120 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65685540 |
121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64947752 |
122 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64595998 |
123 | Morphine addiction_Homo sapiens_hsa05032 | 0.63840499 |
124 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62228178 |
125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61091264 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60439008 |
127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60403096 |
128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59642301 |
129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59013370 |
130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58839139 |
131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58799277 |
132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58628141 |
133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58317142 |
134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58113580 |
135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57859862 |
136 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57498688 |
137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56938861 |
138 | Platelet activation_Homo sapiens_hsa04611 | 0.56732434 |
139 | Bladder cancer_Homo sapiens_hsa05219 | 0.56169048 |
140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55863856 |
141 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54840375 |
142 | Adherens junction_Homo sapiens_hsa04520 | 0.54767468 |
143 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54491851 |
144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54092471 |
145 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.53203871 |
146 | Amoebiasis_Homo sapiens_hsa05146 | 0.52789230 |
147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52632793 |
148 | Endocytosis_Homo sapiens_hsa04144 | 0.52551077 |
149 | Melanogenesis_Homo sapiens_hsa04916 | 0.50819868 |
150 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50246374 |
151 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50122297 |